• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dynavax Technologies Corp

+ Add to Watchlist


1.4570 USD 0.0870 6.35%

As of 20:10:00 ET on 07/29/2014.

Snapshot for Dynavax Technologies Corp (DVAX)

Open: 1.3700 Day's Range: 1.3700 - 1.4800 Volume: 6,969,256
Previous Close: 1.3700 52wk Range: 1.1000 - 2.1400 1-Yr Rtn: +13.83%

Stock Chart for DVAX

No chart data available.
  • DVAX:US 1.4650
  • 1D
  • 1M
  • 1Y
Interactive DVAX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DVAX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3055
Est. EPS (USD) (12/2014) -0.2500
Est. PEG Ratio -
Market Cap (M USD) 382.98
Shares Outstanding (M) 262.86
30 Day Average Volume 2,259,544
Price/Book (mrq) 2.2029
Price/Sale (ttm) 24.3174
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DVAX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DVAX

Dynavax Technologies Corporation discovers, develops, and is seeking to commercialize products based on immunostimulatory sequences. The Company is developing products to treat and prevent allergies, infectious diseases, and chronic inflammatory diseases using approaches that alter immune system responses in specific ways.

Eddie GrayChief Executive OfficerRobert Lee CoffmanSenior VP/Chief Scientific
David L JohnsonVP/Chief Acctg OfficerMichael S OstrachVP/Chief Bus Ofcr/Secy/Gen Cnsl
More Company Profile & Key Executives for DVAX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil